Validation of the EPIPHANY index for predicting risk of serious complications in cancer patients with incidental pulmonary embolism.
AffiliationDepartment of Emergency Medicine, Cancer Emergency Room, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
MetadataShow full item record
AbstractThe EPIPHANY index was developed to classify cancer associated pulmonary embolism (PE) into different risk categories using decision tree modeling. In this study, we tried to externally validate this index in a distinct group of patients solely composed of incidental PE (IPE).
CitationValidation of the EPIPHANY index for predicting risk of serious complications in cancer patients with incidental pulmonary embolism. 2018, Support Care Cancer
JournalSupportive Care in Cancer